Adnexus Raises Series C

Adnexus Therapeutics Inc., a Waltham, Mass.-based developer of therapeutic proteins, has raised $15.5 million in Series C funding. HBM BioVentures led the deal, and was joined by return backers Atlas Venture, Flagship Ventures, Polaris Venture Partners and Venrock. AdNexus has raised $70 million in total VC funding since 2003. Its first candidate focuses on oncology, and is in Phase I clinical trials.